InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Tucker John H, Chairman & CEO. Director active across 1 companies, notably scPharmaceuticals Inc.. Aggregated, 2 filings have been recorded. Total volume traded: €70k. The latest transaction was filed on 3 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€34,98310,000 shares@ €3.4983100.0% of flow
Common Stock
SEC:0000899243-21-046979·
Ideal exit: 30 Aug 2022 (T+270)
€34,98310,000 shares@ €3.498350.0% of flow
Common Stock
SEC:0000899243-21-046979:0·
Ideal exit: 30 Aug 2022 (T+270)
2 of 2 declarations
About Tucker John H
John H. Tucker serves as President and Chief Executive Officer of scPharmaceuticals Inc. As CEO, he leads the company and is responsible for overall strategy and operations. His expertise in the pharmaceutical sector is essential for driving innovation and growth at scPharmaceuticals.
